✦ LIBER ✦

Toxic effects of dopamine metabolism in Parkinson's disease

✍ Scribed by Nobutaka Hattori; Mei Wang; Hikari Taka; Tsutomu Fujimura; Asako Yoritaka; Shin-ichiro Kubo; Hideki Mochizuki

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Opioid peptides in Parkinson's disease:

✍ Fabio Baronti; Katherine E. Conant; Marianne Giuffra; Thomas L. Davis; Giorgio B 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Dopamine agonists + levodopa cost effect

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Dopamine Agonists in Parkinson’s Disease

✍ Stocchi, Fabrizio 📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 288 KB

Dopamine receptors in Parkinson's diseas

✍ Hassan, Mohamed N.; Thakar, Jay H. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 668 KB

Dopamine agonists in Parkinson’s disease

✍ Tintner, Ron; Jankovic, Joseph 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 200 KB

Symptomatic and neuroprotective effects

✍ P. Jenner 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 145 KB